Editor
In response to the rapid spread of COVID‐19 at the start of the pandemic, governments introduced severe measures of home confinement and isolation of the population in an effort to prevent their health systems from collapsing. On March 14, with more than 4000 confirmed cases, 1 Spain began its nationwide lockdown which has extended for almost three months.
In recent weeks, numerous articles have reported a wide range of skin symptoms of COVID‐19, 2 but there are other dermatological conditions that may have been aggravated during this global pandemic. Scabies is a highly contagious skin infestation caused by the mite Sarcoptes scabiei (variety hominis). In developed countries, scabies is usually observed sporadically or as institutional outbreaks in hospitals, nursing homes, prisons, long‐term care facilities or in displaced persons and asylum seekers. 3 , 4 However, we have observed a significant increase of scabies cases in our region during the confinement period (March, April and May 2020) compared to the average for the same period during the previous five years (64 vs. 18.6 patients).
In an attempt to analyse how the confinement had influenced the scabies infestation, we have compared the characteristics of the patients diagnosed by dermatologists (based on clinical and dermatoscopic criteria) in that quarter during the last five years with those diagnosed during the confinement (Table 1). The lockdown changed not only the number of patients infested, but also the features of the disease and our management (Fig. 1).
Table 1.
Comparison of demographic, clinical and therapeutic data between scabies cases diagnosed during the months of confinement and non‐confinement
Confinement† | No confinement‡ | Statistical comparison | |
---|---|---|---|
N | 64 | 93 | |
Gender | |||
Male | 32 | 48 | χ2 (1) = 0.01, P > 0.05 |
Female | 32 | 45 | |
Age (mean + SD) | 30.87 ± 21.28 | 32.16 ± 25.11 | t (155) = −0.336, P > 0.05 |
Cohabitants + | 52 (81.25%) | 61 (65.59%) | χ2 (1) = 3.865, P < 0.05 |
Family Cluster | 35 (54.68%) | 18 (19.35%) | χ2 (1) = 19.61, P < 0.05 |
Symptoms duration | 9.75 ± 5.85 | 5.77 ± 5.172 | (t (154) = 4.47, P < 0.05) |
Previous treatment | 48 (75%) | 14 (15.05%) | χ2 (1) = 54.53, P < 0.05 |
Treatment with permethrin | 64 (100%) | 93 (100%) | |
Previous applications of permethrin (mean + SD) | 4.10 ± 2.94 | 1.64 ± 0.84 | t(59.9) = −5.123, P < 0.05 |
Treatment with ivermectin | 36 (60.93%) | 4 (4.3%) | χ2 (1) = 58.33, P < 0.05 |
Period between March and May 2020.
Period between March and May from 2015 to 2019.
Figure 1.
Home confinement effect on scabies infestation.
First, spending more time at home and therefore with relatives, increases the risk of transmitting the parasite through direct contact or by fomites, a rise that has also been observed during the winter season. 5 Second, we observed that during the period of confinement, the duration of symptoms reported by patients was significantly longer. This seems to be explained by the population's fear of leaving home unless it was strictly necessary, not seeking medical attention until they got desperate by the pruritus. The detection and treatment of the index case is the most effective measure to stop scabies spread, and this delay in diagnosis may have led to an increased intrafamilial transmission in our sample, as it is described in other studies. 6 , 7 The proportion of patients with history of family members or cohabitants diagnosed with scabies (or suspected) was significantly higher in the confinement group, reaching more than the 80%; and more than the half of our sample consulted the dermatologist with their cohabitants, conforming ‘family clusters’, while only a 20% did in the non‐confinement group.
Regarding to treatment, all members of our sample were treated with topical 5% permethrin cream, as it is the first‐line treatment in our country 8 ; however, there is a higher proportion of patients who had already been treated by their primary healthcare providers during confinement because general practitioners made an effort to avoid hospital referral of non‐urgent conditions due to the public health situation. In addition, the number of permethrin applications in confined patients was significantly superior, and therefore, this group ended requiring oral treatment with ivermectin more frequently. Permethrin failure has often been observed in major outbreaks in institutions, due to complications in carrying out decontamination measures or in completing topical treatment, with frequent reinfections among cohabitants. On these occasions, oral treatment with ivermectin is considered as the first choice for controlling infestation. 4 , 8 , 9 In our opinion, during home confinement, minor outbreaks have arised within each family group, and management difficulties are similar to those previously mentioned for institutional outbreaks, so perhaps the approach should be similar.
The results presented are from a single hospital in Spain, and these results cannot be generalized; however, due to the dramatic evolution of the pandemic, we could suffer again a confinement and this work provides a basis for future researchers to implement and evaluate preventive actions to reduce and recognize early cases of scabies in this context.
Conflict of interest
None declared.
Funding sources
There has been no financial support for this work that could have influenced its outcome.
References
- 1. Informe COVID‐19 nº 9 . 13 de marzo de 2020. Ministerio de Sanidad; 2020.
- 2. Wollina U, Karadağ AS, Rowland‐Payne C, Chiriac A, Lotti T. Cutaneous signs in COVID‐19 patients: a review [published online ahead of print, 2020 May 10]. Dermatol Ther 2020: e13549. 10.1111/dth.13549 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Micali G, Lacarrubba F, Verzì AE, Chosidow O, Schwartz RA. Scabies: advances in noninvasive diagnosis. PLoS Negl Trop Dis 2016; 10: e0004691. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Thean LJ, Engelman D, Kaldor J, Steer AC. Scabies: new opportunities for management and population control. Pediatr Infect Dis J 2019; 38: 211–213. [DOI] [PubMed] [Google Scholar]
- 5. Mueller SM, Gysin S, Schweitzer M et al. Implementation and evaluation of an algorithm for the management of scabies outbreaks. BMC Infect Dis 2019; 19: 200. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. de Beer G, Miller MA, Tremblay L, Monette J. An outbreak of scabies in a long‐term care facility: the role of misdiagnosis and the costs associated with control. Infect Control Hosp Epidemiol 2006; 27: 517–518. [DOI] [PubMed] [Google Scholar]
- 7. Ariza L, Walter B, Worth C, Brockmann S, Weber ML, Feldmeier H. Investigation of a scabies outbreak in a kindergarten in Constance, Germany. Eur J Clin Microbiol Infect Dis 2013; 32: 373–380. [DOI] [PubMed] [Google Scholar]
- 8. Sunderkötter C, Feldmeier H, Fölster‐Holst R et al. S1 guidelines on the diagnosis and treatment of scabies – short version. J Dtsch Dermatol Ges 2016; 14: 1155–1167. [DOI] [PubMed] [Google Scholar]
- 9. Middleton J, Walker SL, House T, Head MG, Cassel JA. Ivermectin for the control of scabies outbreaks in the UK. Lancet 2019; 394: 2068–2069. [DOI] [PubMed] [Google Scholar]